Sort
48,018 grants matching “immunotherapy”
CLINICAL IMAGING AND RADIATION DOSIMETRY
$421,976James R Bading · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$421,954Udai S Kammula · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer
$421,954Udai S Kammula · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cell migration and virological synapse formation in parenteral HIV transmission
$421,926Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DA
Cell migration and virological synapse formation in parenteral HIV transmission
$421,926Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DA
Cell migration and virological synapse formation in parenteral HIV transmission
$421,926Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DA
Core D: Antigen Receptor Identification and Tracking Core
$421,903Nir Hacohen · Massachusetts General Hospital · U19 · FY2021 · AI
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$421,762Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
$421,755Paul Nghiem · University Of Washington · P01 · FY2020 · CA
Intra- and inter-cellular signals that drive hepato-oncogenesis
$421,749Gen-Sheng Feng · University Of California, San Diego · R01 · FY2021 · CA
Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer
$421,729Edgar G. Engleman · Stanford University · R01 · FY2019 · CA
Project #1 Bar and Shaw
$421,707Katharine June Bar · University Of Pennsylvania · P01 · FY2017 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP
$421,699University Of Pennsylvania · U10 · FY2004 · CA
Discovery Methods for Functional Immune Niches in Cancer
$421,685Matthew F Krummel · University Of California, San Francisco · R21 · FY2025 · CA
Inhibition of pleiotrophin to combat pancreatic cancer metastasis
$421,685Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2024 · CA
Elucidating the role of T-regs in engraftment, GVHD, and DLI immunotherapy
$421,685Christene A Huang · Massachusetts General Hospital · R01 · FY2011 · AI
Targeting a Novel Secreted Immune Checkpoint to Enhance Liver Cancer Immunotherapy
$421,685Yalan Deng · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
Pan-cancer Analysis of Convergent Immunoglobulins from Tumor-infiltrating B Cells
$421,685Bin Liu · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
ApoFasL: a Novel Immunotherapeutic for T1D
$421,676Rolf M Huseby · Apovax, Inc. · R43 · FY2007 · DK
Impact of senescence on T-cell function and immunotherapeutic response
$421,651Christin E Burd · Ohio State University · R01 · FY2020 · AG
Mechanisms for post-COVID pituitary damage
$421,625Takako Araki · University Of Minnesota · R01 · FY2021 · DK
Engineering Oral Tumor Microcirculation: Blood and lymphatic capillary network-enabled Human Oral Tumor Microenvironment Chips for Preclinical Research
$421,625Abhishek Jain · Texas Engineering Experiment Station · R21 · FY2025 · DE
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$421,611Edgar G. Engleman · Stanford University · P01 · FY2022 · CA
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$421,608Edgar G. Engleman · Stanford University · P01 · FY2023 · CA
CLINICAL SCALE EXPANSION OF HUMAN DENDRITIC CELLS
$421,537Aastrom Biosciences, Inc. · R44 · FY2001 · CA